ValiRx - Successful Evaluation of Triple Negative Breast Cancer Programme

Dr. Suzy Dilly, CEO of ValiRx, discusses the successful evaluation of the company's triple negative breast cancer programme.

Suzanne Dilly
Chief Executive Officer

Company Events - VALIRX PLC